Apple: Analysts Anticipate Q3 Revenues Of $73.3 Billion

Apple (NASDAQ: AAPL) will be reporting their fiscal third quarter on July 27th after market close. Analysts have a consensus $159.98 12-month price target on the company, via a total of 41 analysts, with 12 analysts having strong buy ratings. 21 analysts meanwhile have buy ratings, 7 have hold ratings, and one has a strong sell on the company. The street high comes from Wedbush Securities with a $185 price target, and the lowest target sits at $125 from Wolfe Research.

25 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 25 analysts is $73.276 billion; this number has been revised upwards from $66.284 billion at the start of the year. The highest revenue estimate is $77.054 billion, while the lowest is $65.682 billion.

Onto EBITDA estimates, there are currently only 9 analysts who have third-quarter EBITDA estimates. The mean is currently $22.516 billion, with this number having been revised up from $18.4 billion at the start of the year. Street high is a $24.44 billion EBITDA estimate and the lowest is $18.868 billion.

Analysts estimate that quarterly earnings per share will come in at $1.01, with this number being revised up from $0.76 at the start of the year. Street high is currently $1.16 and the lowest estimate is $0.82 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Haywood Reiterates $80 Price Target On Trulieve After Harvest Health Purchase

On October 1st, Trulieve Cannabis (CSE: TRUL) announced that they completed their $1.75 billion acquisition...

Monday, October 11, 2021, 04:43:00 PM

Village Farms: Consensus Estimates For Q4 2020

Village Farms (TSX: VFF) (NASDAQ: VFF) will be reporting their fourth quarter and year end...

Monday, March 15, 2021, 11:43:00 AM

Raymond James Calls Indiva 75% Undervalued, Gives 243% Upside Target

This week, Raymond James initiated coverage on Indiva Limited (TSXV: NDVA) with a $1.75 price...

Thursday, September 9, 2021, 03:42:00 PM

Ayr Wellness: Canaccord Raises Price Target To $70

On March 10th, Ayr Wellness (CSE: AYR.a) reported their fourth quarter and year end financial...

Sunday, March 14, 2021, 02:41:00 PM

Valens Company Sees Canaccord Lower Price Target To $4.25

Last week, The Valens Company (TSX: VLNS) reported its second-quarter financial results. The company announced...

Friday, July 23, 2021, 01:41:00 PM